High-throughput process development (HTPD) shortens development time and increases the amount of information available for quality by design (QbD) approaches. HTPD involves chromatography techniques, which help in better and accurate result prediction and analysis. High throughput process development addresses the concerns regarding the reduction of development time and enhancing the effectiveness of the final product by utilizing core knowledge. Furthermore, usefulness of high throughout tools in performing parallel screening of chromatography issues and media while saving enough time for process developers is boosting this market considerably
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the high throughput process development market.
Top Impacting Factors
- High throughput process development market is anticipated to grow during the forecast period due to increase in R&D spending, technological improvements in process development, and growth within the biopharmaceutical manufacturing. Furthermore, increase in pressure to lower the price of manufacturing is expected to provide growth opportunities to the market during the forecast period.
- High throughput computing has lately emerged as a key area of operation where multiple computers are deployed over an extended period to accomplish a computational task. This can be a key factor contributing to the high throughput process development.
- Growth in the biopharmaceutical industry for manufacturing process can further boosts the market growth.
- However, factors such as high cost of technology & equipment and the lack of adequate infrastructural facilities are restraining the growth of this market to a certain extent.
Market Trends
New Product Launches to Flourish the Market
In March 2018, Sartorius Stedim Biotech launched the Ambr 250 high throughput perfusion, a new automated parallel bioreactor system. It has been specially designed for rapid cell culture perfusion process development to optimize production of therapeutic antibodies.
In April 2021, Thermo Fisher Scientific received authorization from the U.S. Food and Drug Administration for high-throughput and automated COVID-19 Test Kit.
Surge in Usage in R&D for Drug Discovery
Increase in R&D spending, technological advancements in process development, development of the biopharmaceutical industry, increase in demand for technical instruments to improve the quality of biological materials production, and increase in pressure to lower the cost of manufacturing are some factors which upsurge the market growth.
Key Benefits of the Report
- This study presents the analytical depiction of the high throughput process development industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.
Questions Answered in the High-throughput Process Development Market Report
- Which are the leading players active in the high-throughput process development market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is high-throughput process development "?
- What is high-throughput process development market prediction in the future?
- Who are the leading global players in the high-throughput process development market?
- What are the current trends and predicted trends?
- What are the key benefits of the high-throughput process development market report?
High Throughput Process Development Market, by Product Type Report Highlights
| Aspects | Details |
 By Product Type |
|
 By Technology |
|
 By Molecule type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Tecan Group, GE Healthcare, Merck Millipore, Eppendorf, Perkinelmer, Danaher Corporation, Bio-Rad Laboratories, Agilent Technologies, Thermo Fisher Scientific Inc., Sartorius Stedim Biotech |
Loading Table Of Content...
